Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Zhengye Biotechnology Holding (ZYBT) Equity Ratio (2023 - 2025)

Zhengye Biotechnology Holding has reported Equity Ratio over the past 3 years, most recently at 0.7 for Q4 2025.

  • Quarterly Equity Ratio fell 1.68% to 0.7 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.7 through Dec 2025, down 1.68% year-over-year, with the annual reading at 0.7 for FY2025, 22.06% up from the prior year.
  • Equity Ratio was 0.7 for Q4 2025 at Zhengye Biotechnology Holding, down from 0.72 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.72 in Q2 2025 and troughed at 0.68 in Q4 2023.
  • The 3-year median for Equity Ratio is 0.71 (2024), against an average of 0.7.
  • Year-over-year, Equity Ratio grew 5.31% in 2024 and then decreased 1.68% in 2025.
  • A 3-year view of Equity Ratio shows it stood at 0.68 in 2023, then rose by 5.31% to 0.71 in 2024, then fell by 1.68% to 0.7 in 2025.
  • Per Business Quant, the three most recent readings for ZYBT's Equity Ratio are 0.7 (Q4 2025), 0.72 (Q2 2025), and 0.71 (Q4 2024).